Check out your Company Bowl for anonymous work chats.
At the JPM Healthcare Conference this week, our CEO Stephen Gillett presented Verily’s core strategy aligned with our mission to bring the promise of precision health to everyone, every day. If you weren’t able to be there in person, here are the highlights: ❇️ Solving the data silo problem: 97% of healthcare data is inaccessible and not fit to be analyzed for healthcare. Verily is building the infrastructure to connect, standardize, and activate this data to be AI-ready. ❇️ Verily Pre: Our strategy is built around this AI-native precision health platform designed to harmonize and enrich multimodal data for use in healthcare AI, using our proprietary FHIR-based clinical model. ❇️ Dual DNA of tech and healthcare: Verily was born from Google X, The Moonshot Factory and partnered early with a provider group to deliver care in all 50 states. We have a decade of experience delivering chronic care programs, and designing and executing clinical studies. Verily's expertise enables us to serve patients and customers with the regulatory, safety and clinical standards that are critical to healthcare, while developing leading technologies to help our customers adopt AI safely. ❇️ Key partnerships: We’re collaborating with NVIDIA to integrate their AI capabilities into Verily Pre, and partnering with the University of Colorado on AI-powered research and care.
Meet Verily Pre, our platform designed to accelerate AI for precision health. Pre is the cornerstone of our data and tech infrastructure, transforming complex, multimodal healthcare datasets for use in healthcare AI. It includes three complementary solutions: ❇️ Refinery: Our powerful curation engine for structured, research and AI-ready data assets ❇️ Exchange: A centralized forum for sharing and accessing datasets, models, and agents ❇️ Workbench: Our highly scalable trusted research environment used by over 20K researchers today
🔮 What’s your prediction for health AI in 2026? Our Chief Product Officer, Myoung Cha, weighed in on the STAT AI Prognosis predictions, foreseeing a big shift: a majority of patients will use AI before a doctor visit. Read more expert predictions from Brittany Trang and see what’s on your own bingo card for the future of health tech.
"With NVIDIA's cutting-edge AI capabilities now available in our Verily Pre platform, we are providing researchers with unparalleled tools to enhance the speed and efficiency of AI model development and omics analysis, ultimately accelerating the understanding of disease and advancing precision health for everyone." - Stephen Gillett, Verily CEO If you’ll be at the J.P. Morgan Healthcare Conference next week, you can hear more from Stephen Gillett on Tuesday, January 13 at 5:30 PM PT at the Westin Saint Francis in San Francisco.
What if you could connect health data to better predict and prevent negative outcomes, and make care more precise? Watch to see how Verily Pre can help get you there.
Our CEO Stephen Gillett will be at the J.P. Morgan Healthcare Conference discussing Verily's business updates and how Verily Pre, our precision health platform, is enabling healthcare AI for our customers and users. 🗓️ Tuesday, January 13th at 5:30 PM PT 📍 Westin St. Francis, Mission Bay Room, San Francisco, CA
What better way to kick off 2026 than at the CES Digital Health Summit! Vindell Washington, our Chief Clinical Officer, will join fellow experts Aliza Silver, JD MPH, Benjamin Zaniello, MD MPH, and Meg Barron at the Health Industry Leaders Forum to discuss the future of health care. They’ll explore the role technology will play, including opportunities and challenges. If you’re attending, join the discussion today, January 5 at 2:20 PM PT.
As 2025 comes to a close, we want to pause and express our deep gratitude for our customers, partners and employees. We're energized by the opportunities ahead to create meaningful impact in healthcare together. Merry Christmas and happy holidays! Wishing you a joyful season filled with peace, happiness, and success in the coming year. Please note that our offices will be closed starting December 24 through January 1. We’ll see you at the start of 2026 🎊
While healthcare is rapidly accelerating the development of LLM-based health agents, the industry still lacks a standardized way to measure how effectively these models retrieve and reason over actual FHIR data. In collaboration with the Massachusetts Institute of Technology and Korea Advanced Institute of Science and Technology, Verily created FHIR-AgentBench — a rigorous, open-source framework to evaluate how AI retrieves and reasons over complex patient records — establishing a new standard for building safer, more reliable health AI systems. The Result? We moved the needle, increasing accuracy from 50% to 80% on complex clinical question-answering tasks. We’re open-sourcing the benchmark to help the industry build more reliable, high-fidelity AI systems for precision health. Read the full technical deep-dive from Verily Senior Data Scientist Jong Ha L. and Data Scientist Eléa Bach.
It’s not enough to simply detect pathogens in wastewater; public health leaders need to understand how they move to make informed decisions. Our partner team at Bangor University is utilizing advanced models to simulate how viruses disperse from rivers to coastal waters. This data creates spatial risk maps, helping governments visualize contamination zones and anticipate outbreaks, even during extreme weather events. Verily is translating these models into clearer, smarter risk assessments for public health: https://viraqua.uk/en/our-science/models
